Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
about
Genomic profiling reveals mutational landscape in parathyroid carcinomasBioinformatics Education in Pathology Training: Current Scope and Future Direction.DNA Sequence Analysis in Clinical Medicine, Proceeding Cautiously.Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.Data resources for the identification and interpretation of actionable mutations by clinicians.Managing the genomic revolution in cancer diagnostics.The ins and outs of molecular pathology reporting.Ethical considerations in genomic testing for hematologic disorders.A novel molecular diagnostics platform for somatic and germline precision oncology.Implementation and utilization of the molecular tumor board to guide precision medicine.Clinical applications of genome studies.Resources for Interpreting Variants in Precision Genomic Oncology Applications.Houston Methodist Variant Viewer: An Application to Support Clinical Laboratory Interpretation of Next-generation Sequencing Data for Cancer.Next-generation sequencing: recent applications to the analysis of colorectal cancer.ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research.Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.Bioinformatics for precision oncology.Clinical Impact of Genomic Information in Pediatric Leukemia.Implementation of "Clinical Sequencing" in Cancer Genome Medicine in Japan.eGARD: Extracting associations between genomic anomalies and drug responses from text.Development of pulmonary Langerhans cell histiocytosis in a patient with established adenocarcinoma of the lung.Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis.Identification of a Rare Germline Heterozygous Deletion Involving the Polycistronic miR-17-92 Cluster in Two First-Degree Relatives from a BRCA 1/2 Negative Chilean Family with Familial Breast Cancer: Possible Functional Implications.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer.The evidence framework for precision cancer medicine.Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.Genome sequencing identifies somatic BRAF duplication c.1794_1796dupTAC;p.Thr599dup in pediatric patient with low-grade ganglioglioma.PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease.New additions to the cancer precision medicine toolkit.Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.Authors' Reply.The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research.A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?Clinical validation of the Tempus xO assay.
P2860
Q30360213-885D1865-A45B-4266-AF64-E5F6E901D4AAQ33565853-07BDA367-9390-4A03-880E-3452BFD2EE8AQ33627712-6E5C46F8-37D0-4344-81DC-01256CC13E43Q33729699-EBCCB24C-5C71-4609-8747-934FC15E1EA6Q36317783-F128955E-9FD3-4E87-87D5-8F55BFA6ACA7Q38714606-368AD706-F035-4359-8589-A574939C70A1Q38875985-401A48F9-DCC6-4772-BA60-F9291DBE2FB5Q39363424-FF32D05D-A0AE-47F8-8A5C-45DA127814FBQ41023790-5391D86A-0E46-4ED3-A1E1-1813426F2297Q41339458-B63169BA-3524-49A2-985C-54BB2DEC5A05Q41692369-92092746-FB70-4DF3-AAA6-B36D252A13DCQ42363061-47DD0E14-3BEF-41CF-89DA-95B049266D92Q45988384-53DA9463-582C-47A4-AA74-E27AB74654E0Q47107418-F8C0F4AD-565D-44A7-BB12-2B3C14504726Q47124495-BAA0577B-0F9E-4A16-BC14-B9C622424929Q47158332-A89BFB3D-4C84-4184-9B09-DAF999B20A0FQ47159292-A2411919-3F22-4233-AF28-9F9A8F7EFD0DQ47186490-954ED0F4-C2B5-469F-92F7-4082A52C3F00Q47221791-D0F07FAD-E8CE-4FD2-A556-023503BAC41FQ47235804-818A5A46-5A0E-43C9-8F68-B5ACC00300D1Q47271155-AE3D3AE3-D340-4EDC-BD24-9F77B486082CQ47274741-D43F5621-890D-4BB9-8ACA-DBD7324A8640Q47319640-3E5BA3DA-2DC0-4613-9161-6DC6F1F54C3DQ47770082-29FF9186-71F0-4846-AAAF-3D706770D95CQ48182576-4709953B-9F19-4952-8DA1-CBF341B9DAC8Q48317424-67908DE7-21C1-4B2D-BFF6-65C13EA69638Q48502619-3BB18061-1A33-4335-A69F-29F9D57743F1Q49644220-92B1F0D7-EE26-47B9-A541-EF562C8D3450Q49719290-65DDA28F-9FCE-48D0-9FD2-CB57FE542F87Q50056322-BEFEE9EA-B21A-49B9-87ED-D7CCC8C333C9Q50115884-02AC0A6B-C929-4FC2-B340-4FD5442D40CDQ50926408-084F3227-48A6-4A88-89C1-976D2FE0C879Q52571488-49818266-FBA5-4B03-89D0-6688992221D1Q52589511-8C2A90C9-24E0-4ABD-85AE-8025DAD128EBQ52611832-3F4C1428-AA6A-4257-9A60-2B9303AE1170Q52746264-98895D4D-10D0-4312-BE33-30D1E45BEEECQ53108123-508F69A8-8948-4C37-9021-36F78459F389Q54958583-57CFEBB5-8598-4E02-8F5B-B69F5F45B1DCQ54996932-EFB1C364-2A31-44E1-BEE8-FCAF6D7E8D9AQ55091748-6740712C-EA9A-4396-AC5A-3B083F5F9F43
P2860
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Standards and Guidelines for t ...... lege of American Pathologists.
@en
Standards and Guidelines for t ...... lege of American Pathologists.
@nl
type
label
Standards and Guidelines for t ...... lege of American Pathologists.
@en
Standards and Guidelines for t ...... lege of American Pathologists.
@nl
prefLabel
Standards and Guidelines for t ...... lege of American Pathologists.
@en
Standards and Guidelines for t ...... lege of American Pathologists.
@nl
P2093
P2860
P1476
Standards and Guidelines for t ...... lege of American Pathologists.
@en
P2093
Anas Younes
Cindy L Vnencak-Jones
Daynna J Wolff
Eric J Duncavage
Marilyn M Li
Marina N Nikiforova
Michael Datto
Neal I Lindeman
Shashikant Kulkarni
P2860
P356
10.1016/J.JMOLDX.2016.10.002
P577
2017-01-01T00:00:00Z